These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4302972)

  • 1. [Vascular action of angiotensin: balance between peripheral vasoconstrictive influences and vasodilating influences of central origin].
    Malméjac J; Rieu M; Roux A
    C R Seances Soc Biol Fil; 1968 Oct; 162(3):613-5. PubMed ID: 4302972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Could angiotensin have a vasodilator action?].
    Ducrot H; Astoin M
    Union Med Can; 1968 Sep; 97(9):1233-6. PubMed ID: 4320632
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasoconstrictive drugs increase carbonic anhydrase I in vascular smooth muscle while vasodilating drugs reduce the activity of this isozyme by a direct mechanism of action.
    Puscas I; Coltau M; Baican M; Pasca R; Domuta G; Hecht A
    Drugs Exp Clin Res; 2001; 27(2):53-60. PubMed ID: 11392054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of angiotensin cofactor.
    Berman LB; Roza O; Mitra S; Vertes V
    Am J Physiol; 1971 May; 220(5):1332-6. PubMed ID: 4324943
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study of the vasodilating action of Midocalm].
    Gereg P; Sporni L; Ezer E
    Farmakol Toksikol; 1967; 30(1):41-3. PubMed ID: 4874995
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological effects on the mesenteric vessels studied by a new chamber technique.
    Heisig N; Siemssen S
    Bibl Anat; 1967; 9():55-60. PubMed ID: 6029905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Responsiveness of peripheral blood vessels to physiologically vasoactive agents in myocardial infarct].
    Shterental' ISh; Merzhievskaia VM; Nikolaeva AA; Bondareva ZG; Oteva EA; Popova LV
    Kardiologiia; 1989 Nov; 29(11):87-91. PubMed ID: 2615185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can angiotensin have a vasodilating action?].
    Ducrot H; Astoin M
    Pathol Biol; 1968 May; 16(9):525-8. PubMed ID: 4300845
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: A physiological study on the releasing mechanism of plasminogen activator from the vascular wall.
    Kitaguchi H; Izaki S
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188798
    [No Abstract]   [Full Text] [Related]  

  • 10. Interplay of vasodilator and vasoconstrictor substances in the femoral arterial bed: identification of the angiotensin cofactor.
    Haas E; Goldblatt H; Lewis L; Gipson EC
    Lab Invest; 1973 Jan; 28(1):1-7. PubMed ID: 4347553
    [No Abstract]   [Full Text] [Related]  

  • 11. [A pharmacological approach to the problem of the pathology of vascular tonus].
    Votchal BE; Zhmurkin VP
    Klin Med (Mosk); 1968 Oct; 46(10):10-7. PubMed ID: 5717597
    [No Abstract]   [Full Text] [Related]  

  • 12. Localisation of receptors that initiate reflex vascular responses to vasoactive substances.
    Li DM; Bentley GA
    Pflugers Arch; 1971; 325(3):199-219. PubMed ID: 4325553
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of vasoactive humoral agents on the rumen and femoral artery area blood supply in sheep].
    Garbuliński T; Lój W; Debowy J; Dynarowicz I
    Acta Physiol Pol; 1970; 21(6):767-76. PubMed ID: 4321538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vascular aion of bradykinin--experiments in the isolated rabbit ears perfused with the autologous blood].
    Hirako I
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):83-92. PubMed ID: 5387681
    [No Abstract]   [Full Text] [Related]  

  • 15. Agonists and antagonists of vascular receptors.
    Saxena PR
    Adv Neurol; 1982; 33():309-14. PubMed ID: 7034489
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of chlorthalidone on blood vessels.
    Zsotér TT; Hart F; Radde IC; Endrenyi L
    J Pharmacol Exp Ther; 1972 Mar; 180(3):723-31. PubMed ID: 4335113
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug modification of digital vascular reactivity to vasoactive substances.
    Naftchi NE; Mendlowitz M
    Bibl Anat; 1969; 10():137-44. PubMed ID: 4337055
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of human adrenomedullin on a canine tibial perfusion model in the absence of vascular endothelium.
    Kato T; Bishop AT; Wood MB
    J Orthop Res; 1996 Nov; 14(6):956-61. PubMed ID: 8982139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical aspects of vascular pharmacology (literature review)].
    Nikulin AA; Smirnov PA
    Farmakol Toksikol; 1971; 34(4):504-9. PubMed ID: 4400799
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prerequisites for the effect of so-called vaso-active agents].
    Horácek J
    Cesk Dermatol; 1972 Feb; 47(1):33-8. PubMed ID: 5011692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.